2m 2m 2m 2m 2m 2m 2m
MANNKIND (MNKD)
NASDAQ
$3.94+$0.04 (+1.16%)
Price as of Jun 23, 2026 7:57 PM EDT- $1.2BMarket Cap
- 2.50%1-Year Change
- BiotechnologyIndustry
MANNKIND (MNKD)
$3.94+$0.04 (+1.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 114.1M -60.02% | 285.5M +43.50% | 199.0M +99.42% | 99.8M +32.25% | |
Cost of Revenue | 61.2M -48.32% | 118.3M +182.39% | 41.9M +1.00% | 41.5M +88.40% | |
Gross Profit | 53.0M -68.31% | 167.2M +6.43% | 157.1M +169.50% | 58.3M +9.09% | |
Sales and Marketing Expense | 144.1M +52.80% | 94.3M +82.19% | 51.8M -3.68% | 53.8M -30.57% | |
Research and Development Expense | -66.3M +44.57% | -45.9M +46.70% | -31.3M -5.07% | -33.0M +29.00% | |
Depreciation and Amortization Expense | 12.3M +66.65% | 7.4M +62.54% | 4.5M -25.95% | 6.1M +45.29% | |
Total Operating Expenses | 310.2M +45.67% | 212.9M +11.89% | 190.3M +16.11% | 163.9M +33.82% | |
Operating Profit | 38.8M -46.55% | 72.6M +736.45% | 8.7M +113.54% | -64.1M +36.34% | |
Interest Income | 8.1M -36.16% | 12.6M +104.99% | 6.2M +144.89% | 2.5M +2,143.75% | |
Interest Expense | -38.0M +0.13% | -38.0M +150.68% | -15.2M +0.93% | -15.0M -1.27% | |
Interest Income and Expense and Net | -30.0M +18.17% | -25.4M +181.94% | -9.0M -28.01% | -12.5M -17.19% | |
Total Nonoperating Income and Expense | -37.4M -11.11% | -42.1M +120.78% | -19.1M -18.18% | -23.3M -31.31% | |
Income before Taxes | 1.4M -95.39% | 30.5M +394.09% | -10.4M -88.13% | -87.4M +8.00% | |
Income Taxes | -4.5M -252.08% | 2.9M +87.70% | 1.6M N/A | 0 N/A | |
Extraordinary Items | 6.6M N/A | N/A N/A | 106,000 0.00% | 106,000 0.00% | |
Net Income | 5.9M -78.75% | 27.6M +331.09% | -11.9M -86.34% | -87.4M +8.00% | |
Net Income from Continuing Operations Applicable to Common | 1.4M -95.39% | 30.5M +394.09% | -10.4M -88.13% | -87.4M +8.00% | |
Basic EPS and Net Income | 0.02 -80.00% | 0.10 +350.00% | -0.04 -88.24% | -0.34 +6.25% | |
Diluted EPS and Net Income | 0.02 -80.00% | 0.10 +350.00% | -0.04 -88.24% | -0.34 +6.25% | |
Basic Weighted Average Shares | 305.6M +11.38% | 274.4M +2.77% | 267.0M +3.86% | 257.1M +3.15% | |
Diluted Weighted Average Shares | 314.1M +10.66% | 283.8M +6.30% | 267.0M +3.86% | 257.1M +3.15% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 74.9M +61.60% | 46.3M -80.57% | 238.5M +241.82% | 69.8M -43.82% | |
Short-Term Investments | 96.5M -36.08% | 150.9M +166.55% | 56.6M -43.99% | 101.1M +26.46% | |
Cash and Cash Equivalents and Short-Term Investments | 171.3M -13.14% | 197.3M -33.16% | 295.1M +72.73% | 170.8M -16.30% | |
Total Current Assets | 291.6M +8.67% | 268.3M -28.14% | 373.4M +58.96% | 234.9M +6.90% | |
Accumulated Depreciation | 113.9M +6.78% | 106.7M +5.06% | 101.5M +3.02% | 98.6M +0.92% | |
Property and Plant and Equipment and Net | 82.4M -3.45% | 85.4M +1.36% | 84.2M +86.63% | 45.1M +23.25% | |
Total Long-Term Assets | 20.1M -24.77% | 26.8M +260.32% | 7.4M -23.59% | 9.7M +18.71% | |
Total Assets | 792.2M +101.14% | 393.8M -17.12% | 475.2M +60.93% | 295.3M -8.06% | |
Income Taxes Payable | 5.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 36.3M +9.88% | 33.0M 0.00% | 33.0M -15.91% | 39.3M -50.19% | |
Total Current Liabilities | 171.0M +108.99% | 81.8M -21.41% | 104.1M +54.73% | 67.3M +39.19% | |
Total Long-Term Debt | 354.4M +883.09% | 36.1M -84.11% | 226.9M +0.65% | 225.4M +0.65% | |
Total Long-Term Liabilities | 50.7M -19.33% | 62.8M -14.80% | 73.7M +1,389.27% | 5.0M 0.00% | |
Total Liabilities | 843.2M +78.40% | 472.7M -34.48% | 721.4M +32.16% | 545.8M +2.89% | |
Retained Earnings | -3.2B -0.18% | -3.2B -0.85% | -3.2B +0.37% | -3.2B +2.79% | |
Total Stockholders Equity | -51.0M -35.26% | -78.8M -67.98% | -246.2M -1.74% | -250.5M +19.67% | |
Total Shares Outstanding | 307.8M +1.61% | 303.0M +12.19% | 270.0M +2.37% | 263.8M +4.90% | |
Cash Flow | |||||
Cash from Operating Activities | 18.3M -57.06% | 42.5M +24.69% | 34.1M +142.26% | -80.7M +30.74% | |
Capital Expenditures | 4.6M -52.89% | 9.7M -77.16% | 42.4M +459.24% | 7.6M -33.81% | |
Cash from Investing Activities | -304.8M +215.37% | -96.6M +4,761.62% | -2.0M -140.79% | 4.9M +103.22% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 315.1M +329.55% | -137.3M -200.48% | 136.6M +538.71% | 21.4M -92.09% | |
Financials Ratio | |||||
Gross Margin | 46.42% -20.72% | 58.55% -25.83% | 78.94% +35.14% | 58.41% -17.51% | |
Operating Margin | 34.00% +33.71% | 25.42% +482.91% | 4.36% +106.79% | -64.26% +3.10% | |
Return on Assets | 0.99% -84.43% | 6.35% +304.89% | -3.10% -89.07% | -28.36% -24.71% | |
Return on Equity | -9.03% -46.81% | -16.98% -453.20% | 4.81% -87.35% | 38.01% -8.47% | |
Revenue Growth | -60.02% -237.99% | 43.50% -56.25% | 99.42% +208.31% | 32.25% +103.99% | |
Current Ratio | 1.70 -48.00% | 3.28 -8.58% | 3.59 +2.74% | 3.49 -23.20% | |
Cash Ratio | 0.44 -22.68% | 0.57 -75.28% | 2.29 +120.92% | 1.04 -59.64% | |
Debt-to-Equity Ratio | -7.66 +773.82% | -0.88 -16.99% | -1.06 -0.07% | -1.06 -26.96% | |
Debt-to-Assets Ratio | 0.49 +181.19% | 0.18 -67.93% | 0.55 -38.98% | 0.90 -4.93% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow